Literature DB >> 5772525

Urinary imidazoles in rheumatoid arthritis.

E N Wardle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5772525      PMCID: PMC1031182          DOI: 10.1136/ard.28.3.310

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  FOLIC-ACID DEFICIENCY IN RHEUMATOID ARTHRITIS.

Authors:  K R GOUGH; C MCCARTHY; A E READ; D L MOLLIN; A H WATERS
Journal:  Br Med J       Date:  1964-01-25

2.  FOLATE METABOLISM AND IRON DEFICIENCY.

Authors:  J J VITALE; R R STREIFF; E E HELLERSTEIN
Journal:  Lancet       Date:  1965-08-21       Impact factor: 79.321

3.  A spectrophotometric method for estimating formimino-glutamic and urocanic acid.

Authors:  I CHANARIN; M C BENNETT
Journal:  Br Med J       Date:  1962-01-06

4.  The assay of aromatic amino acid transaminations and keto acid oxidation by the enol borate-tautomerase method.

Authors:  E C LIN; B M PITT; M CIVEN; W E KNOX
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

5.  Liver function tests in rheumatoid arthritis.

Authors:  P W DARBY
Journal:  J Clin Pathol       Date:  1956-05       Impact factor: 3.411

6.  The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy.

Authors:  A V Hoffbrand; G Neale; J D Hines; D L Mollin
Journal:  Lancet       Date:  1966-06-04       Impact factor: 79.321

7.  An electron microscope study of bone marrow in rheumatoid disease.

Authors:  E N Wardle; J Attan
Journal:  Br J Haematol       Date:  1967-03       Impact factor: 6.998

8.  Determination of urinary 4-aminoimidazole-5-carboxamide.

Authors:  R F Coward; P Smith
Journal:  Clin Chim Acta       Date:  1965-08       Impact factor: 3.786

9.  Excretion of formiminoglutamic acid in reticulosis and carcinoma.

Authors:  S Noeypatimanond; E J Watson-Williams; M C Israëls
Journal:  Lancet       Date:  1966-02-26       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.